This is a preview of subscription content, log in via an institution to check access.
Notes
resource costs (in euros) were based on 2012 National Outpatient Tariffs
Reference
El Hachem M, et al. Cost-utility analysis of propranolol versus corticosteroids in the treatment of proliferating infantile hemangioma in Italy. Pharmacoeconomics - Italian Research Articles 17: No. 2, 1 Jul 2015. Available from: URL: http://dx.doi.org/10.1007/s40276-015-0025-2
Rights and permissions
About this article
Cite this article
Hemangiol cost effective for proliferating infantile haemangioma. PharmacoEcon Outcomes News 735, 16 (2015). https://doi.org/10.1007/s40274-015-2390-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2390-5